Alpha 2.0
Login Register
» Articles » PMID: 12939384

New Developments in Hyperphosphatemia Management

Overview
Journal J Am Soc Nephrol
Specialty Nephrology
Date 2003 Aug 27
PMID 12939384
Citations 5
Authors
Eduardo Slatopolsky
Affiliations
Soon will be listed here.
Citing Articles

Eduardo Slatopolsky: A Pioneer in the Field of Mineral and Bone Disorders in Kidney Disease.

Tinawi M Cureus. 2024; 16(9):e68543.

PMID: 39364464 PMC: 11449467. DOI: 10.7759/cureus.68543.

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients.

Cekic D, Sipahi S, Arman M Caspian J Intern Med. 2023; 14(4):737-740.

PMID: 38024165 PMC: 10646360. DOI: 10.22088/cjim.14.4.737.

Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients.

Lin C, Pan C, Chuang C, Liu H, Huang S, Chen H J Clin Med Res. 2017; 9(9):765-770.

PMID: 28811853 PMC: 5544481. DOI: 10.14740/jocmr1803e.

Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis.

Nabeshima Y Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85(3):125-41.

PMID: 19282648 PMC: 3524302. DOI: 10.2183/pjab.85.125.

Hyperphosphatemia in children receiving peritoneal dialysis--an educational program.

Blaszak R, Mitsnefes M, Ilyas M, Salman S, Belcher S, Brady D Pediatr Nephrol. 2005; 20(7):967-71.

PMID: 15875218 DOI: 10.1007/s00467-005-1884-y.